BACKGROUND: The SARS-CoV-2 pandemic presented major challenges to the health sector in 2020. The burden of disease arising from COVID-19 can be expressed as the number of years of life lost to disease or death. For example, death at age 40 involves a loss of far more years of life than death at age 80. METHODS: The disability-adjusted life years (DALY) lost to COVID-19 were calculated as the sum of the years of life lost through death (YLL) and the number of years lived with disability (YLD), on the basis of laboratory-confirmed notifiable cases of SARS-CoV-2 infection in Germany in 2020 (documented as of 18 January 2021). The methodology was based on that used in the Global Burden of Disease Study. Pre-existing diseases do not enter into the determination of YLL; rather, the residual life expectancy that is applied in this calculation corresponds to a mean age-specific level of morbidity. RESULTS: 305 641 years of life were lost to COVID-19 in Germany in 2020. The percentage of DALY lost by persons under 70 was 34.8% in men and 21.0% in women. 99.3% of the COVID-19 disease burden was accounted for by death (YLL). The daily average years of life lost due to death was lower for COVID-19 than for the major non-communicable diseases. Persons who died of COVID-19 lost a mean of 9.6 years of life; those who were under 70 when they died lost a mean of 25.2 years of life. Men lost more years of life than women (11.0 vs. 8.1 years). CONCLUSION: The effects of COVID-19 on public health can be expressed through the burden of disease indicators. This method yields additional information that should be put to use early in the course of future outbreaks.
BACKGROUND: The SARS-CoV-2 pandemic presented major challenges to the health sector in 2020. The burden of disease arising from COVID-19 can be expressed as the number of years of life lost to disease or death. For example, death at age 40 involves a loss of far more years of life than death at age 80. METHODS: The disability-adjusted life years (DALY) lost to COVID-19 were calculated as the sum of the years of life lost through death (YLL) and the number of years lived with disability (YLD), on the basis of laboratory-confirmed notifiable cases of SARS-CoV-2 infection in Germany in 2020 (documented as of 18 January 2021). The methodology was based on that used in the Global Burden of Disease Study. Pre-existing diseases do not enter into the determination of YLL; rather, the residual life expectancy that is applied in this calculation corresponds to a mean age-specific level of morbidity. RESULTS: 305 641 years of life were lost to COVID-19 in Germany in 2020. The percentage of DALY lost by persons under 70 was 34.8% in men and 21.0% in women. 99.3% of the COVID-19 disease burden was accounted for by death (YLL). The daily average years of life lost due to death was lower for COVID-19 than for the major non-communicable diseases. Persons who died of COVID-19 lost a mean of 9.6 years of life; those who were under 70 when they died lost a mean of 25.2 years of life. Men lost more years of life than women (11.0 vs. 8.1 years). CONCLUSION: The effects of COVID-19 on public health can be expressed through the burden of disease indicators. This method yields additional information that should be put to use early in the course of future outbreaks.
Authors: A Mazick; B Gergonne; J Nielsen; F Wuillaume; M J Virtanen; A Fouillet; H Uphoff; T Sideroglou; A Paldy; A Oza; B Nunes; V M Flores-Segovia; C Junker; S A McDonald; H K Green; R Pebody; K Mølbak Journal: Euro Surveill Date: 2012-04-05
Authors: Alexander Rommel; Elena von der Lippe; Dietrich Plaß; Annelene Wengler; Aline Anton; Christian Schmidt; Katrin Schüssel; Gabriela Brückner; Helmut Schröder; Michael Porst; Janko Leddin; Myriam Tobollik; Jens Baumert; Christa Scheidt-Nave; Thomas Ziese Journal: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Date: 2018-09 Impact factor: 1.513
Authors: Min Woo Jo; Dun Sol Go; Rhieun Kim; Seung Won Lee; Minsu Ock; Young Eun Kim; In Hwan Oh; Seok Jun Yoon; Hyesook Park Journal: J Korean Med Sci Date: 2020-06-01 Impact factor: 2.153
Authors: Annelene Wengler; Heike Gruhl; Dietrich Plaß; Janko Leddin; Alexander Rommel; Elena von der Lippe Journal: Arch Public Health Date: 2021-03-15
Authors: Jonas Dehning; Johannes Zierenberg; F Paul Spitzner; Michael Wilczek; Viola Priesemann; Michael Wibral; Joao Pinheiro Neto Journal: Science Date: 2020-05-15 Impact factor: 47.728
Authors: In Hwan Oh; Minsu Ock; Su Yeon Jang; Dun Sol Go; Young Eun Kim; Yoon Sun Jung; Ki Beom Kim; Hyesook Park; Min Woo Jo; Seok Jun Yoon Journal: J Korean Med Sci Date: 2020-08-17 Impact factor: 2.153
Authors: Johannes Diers; Laura Acar; Philip Baum; Sven Flemming; Carolin Kastner; Christoph-Thomas Germer; Helmut L'hoest; Ursula Marschall; Johan Friso Lock; Armin Wiegering Journal: Dtsch Arztebl Int Date: 2021-07-12 Impact factor: 5.594
Authors: Sara Monteiro Pires; Grant M A Wyper; Annelene Wengler; José L Peñalvo; Romana Haneef; Declan Moran; Sarah Cuschieri; Hernan G Redondo; Robby De Pauw; Scott A McDonald; Lynelle Moon; Jad Shedrawy; Elena Pallari; Periklis Charalampous; Brecht Devleesschauwer; Elena Von Der Lippe Journal: Front Public Health Date: 2022-06-03
Authors: Susanne Breitner; Nadine Steckling-Muschack; Iana Markevych; Tianyu Zhao; Hanna Mertes; Dennis Nowak; Joachim Heinrich Journal: Dtsch Arztebl Int Date: 2021-07-26 Impact factor: 5.594